Dear Colleagues,
I want to thank you all for continuing to protect the nation’s health and support this agency and our leadership team. It has been a privilege for me to serve a second time as Acting Director and get to work with even more of our excellent staff and programs. CDC cannot accomplish the strategic goals we’ve set without your hard work, scientific expertise and the commitment you bring to our public service. You are the key component to maintaining this agency’s position as one of the most respected agencies in federal government. And I am proud to continue to do my part in continuing that legacy as well.
I look forward to working with Dr. Redfield and know I can count on you to provide him the same level of dedication I’ve seen you show in the past. Thanks again for the personal support to me and the professional commitment you have devoted to the public’s health.
Sincerely,
Anne Schuchat, MD (RADM, USPHS)
Acting Director, CDC, and
Acting Administrator, ATSDR
From: HHS Office of Public Affairs
Sent: Wednesday, March 21, 2018 4:35 PM
To: Oakley, Caitlin B. (OS/ASPA)
Subject: HHS Secretary Azar to Name Robert R. Redfield, M.D., Director of the CDC
|
|
|
|
|
News Release |
|
U.S. Department of Health and Human Services |
202-690-6343 |
|
FOR IMMEDIATE RELEASE |
|
HHS Secretary Azar to Name Robert R. Redfield, M.D., Director of the
|
|
On Wednesday, the Department of Health and Human Services announced that Secretary Alex Azar will name Robert R. Redfield, M.D., as the 18th Director of the Centers for Disease Control and Prevention and Administrator of the Agency for Toxic Substances and Disease Registry. Upon the announcement, Secretary Azar issued the following statement: “Dr. Redfield has dedicated his entire life to promoting public health and providing compassionate care to his patients, and we are proud to welcome him as director of the world’s premier epidemiological agency. Dr. Redfield’s scientific and clinical background is peerless: As just one example, during his two-decade tenure at Walter Reed Army Institute of Research, he made pioneering contributions to advance our understanding of HIV/AIDS. His more recent work running a treatment network in Baltimore for HIV and Hepatitis C patients also prepares him to hit the ground running on one of HHS and CDC’s top priorities, combating the opioid epidemic.” “Furthermore, all of us at HHS are grateful to Dr. Anne Schuchat for her service as Acting Director at CDC, especially during this year’s severe flu season. We look forward to CDC continuing its important work on the opioid epidemic and America’s many other pressing public health challenges.” Biographical Background Dr. Robert R. Redfield has been a public health leader actively engaged in clinical research and clinical care of chronic human viral infections and infectious diseases, especially HIV, for more than 30 years. He served as the founding director of the Department of Retroviral Research within the U.S. Military’s HIV Research Program, and retired after 20 years of service in the U.S. Army Medical Corps. Following his military service, he co-founded the University of Maryland’s Institute of Human Virology with Dr. William Blattner and Dr. Robert C. Gallo and served as the Chief of Infectious Diseases and Vice Chair of Medicine at the University of Maryland School of Medicine. Dr. Redfield made several important early contributions to the scientific understanding of HIV, including the demonstration of the importance of heterosexual transmission, the development of the Walter Reed staging system for HIV infection, and the demonstration of active HIV replication in all stages of HIV infection. In addition to his research work, Dr. Redfield oversaw an extensive clinical program providing HIV care and treatment to more than 5,000 patients in the Baltimore/Washington, D.C. community. Dr. Redfield served as a member of the President’s Advisory Council on HIV/AIDS from 2005 to 2009, and was appointed as Chair of the International Subcommittee from 2006 to 2009. He is a past member of the Office of AIDS Research Advisory Council at the National Institutes of Health, the Fogarty International Center Advisory Board at the National Institutes of Health, and the Advisory Anti-Infective Agent Committee of the Food and Drug Administration. |
|
### |